Horizon Therapeutics plc to Present at the Goldman Sachs 43rd Annual Global Health Care Conference

Rhea-AI Summary

Horizon Therapeutics plc (Nasdaq: HZNP) will participate in the Goldman Sachs 43rd Annual Global Health Care Conference on June 14, 2022, at 11 a.m. ET. The event will be available via live webcast on Horizon's website, with a replay accessible for one year post-event. Horizon focuses on developing therapies for rare, autoimmune, and severe inflammatory diseases, emphasizing scientific innovation and patient impact. For further details, visit their website.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in June:

Goldman Sachs 43^rd Annual Global Health Care Conference

• Date: Tuesday, June 14, 2022
• Presentation Time: 11 a.m. ET

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available for one year following the event.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005940/en/

Investor Relations:

Tina Ventura

Senior Vice President,

Chief Investor Relations Officer

investor-relations@horizontherapeutics.com

U.S. Media:

Geoff Curtis

Executive Vice President, Corporate Affairs &

Chief Communications Officer

media@horizontherapeutics.com

Ireland Media:

Gordon MRM

Ray Gordon

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

When is Horizon Therapeutics participating in the Goldman Sachs conference?

Horizon Therapeutics will participate in the Goldman Sachs 43rd Annual Global Health Care Conference on June 14, 2022.

What time is Horizon Therapeutics' presentation at the conference?

Horizon Therapeutics' presentation at the conference is scheduled for 11 a.m. ET.

How can I watch Horizon Therapeutics' conference presentation?

You can watch Horizon Therapeutics' conference presentation live via webcast on their official website.

What is the focus of Horizon Therapeutics?

Horizon Therapeutics specializes in developing medicines for rare, autoimmune, and severe inflammatory diseases.

Where can I find more information about Horizon Therapeutics?

More information about Horizon Therapeutics can be found on their website at www.horizontherapeutics.com.